rs201010803
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_024809.5(TCTN2):c.1751T>A(p.Ile584Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000434 in 1,613,630 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I584M) has been classified as Likely pathogenic.
Frequency
Consequence
NM_024809.5 missense
Scores
Clinical Significance
Conservation
Publications
- Joubert syndrome 24Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Joubert syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Meckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151644Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251484 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461868Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727238 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151762Hom.: 0 Cov.: 30 AF XY: 0.0000270 AC XY: 2AN XY: 74156 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Joubert syndrome Pathogenic:1
- -
Joubert syndrome and related disorders Pathogenic:1
Variant summary: TCTN2 c.1751T>A (p.Ile584Lys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 251484 control chromosomes. c.1751T>A has been reported in the literature in three individuals affected with Joubert Syndrome, presumably from the same family (Bachmann-Gagescu_2015, Phelps_2018). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Meckel-Gruber syndrome;C0431399:Joubert syndrome Pathogenic:1
This sequence change replaces isoleucine, which is neutral and non-polar, with lysine, which is basic and polar, at codon 584 of the TCTN2 protein (p.Ile584Lys). This variant is present in population databases (rs201010803, gnomAD 0.01%). This missense change has been observed in individual(s) with Joubert syndrome (PMID: 26092869). ClinVar contains an entry for this variant (Variation ID: 217698). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt TCTN2 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at